whatshot

SNN   $29.43  0.20% Market Closed After Close 29.12 -1.05%

Smith & Nephew PLC
show_chart Advanced Chart of SNN
Last Events:

2023-08-09 Signal in Stochastic changed from bearish weakening to bearish recovery. The stochastic indicator is in the oversold territory and it heading south. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: main and signal line crossing.

2023-08-09 Signal in RSI changed from bearish weakening to bearish recovery. RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

2023-08-09 Trend Power changed from strong to medium strength.

2023-08-06 Signal in Stochastic changed from bearish to bearish weakening. The stochastic indicator is in the oversold territory and it heading north. These factors indicate that perhaps the downside trend is coming to an end. Last signal: main and signal line crossing.

2023-08-06 Signal in RSI changed from bearish recovery to bearish weakening. RSI indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: exit from the overbought zone.

2023-08-03 Signal in EMA100 changed from bullish reversal to bearish reversal. The price is trying to cross down the moving average line If the intersection will be successful, then a downside trend can be formed.

2023-08-02 Signal in RSI changed from bearish weakening to bearish recovery. RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

2023-08-02 Trend Power changed from slow to strong.

Current temperature: 22.09
ST: 0, Cor:

50-50 Year Forecast
Low with % probability:
Target: 29.86
High with % probability:
Analyst Recommendations:
Number of estimates 3
Target Price Mean 36.17
Mean unverified/preliminary 36.17 / 36.17
Target Price Low / High 32.00 / 39.00
Median / STD DEV 37.50 / 3.69
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell ActivelyBuy
rsi Sell Sell None
macd None None None
stoch None None None
ma20 Sell Sell ActivelyBuy
ma50 None None None
ma100 Sell Sell None
Candlestick PatternOct. 9, 2024 Bullish Belt Hold - is a candlestick that has a long white body and small shadows. It opens on the low of the day. It occurs in a downtrend. Considered to be a bullish reversal pattern.
ISIN US83175M2052
ceo Dr. Deepak S. Nath Ph.D.
Website https://www.smith-nephew.com
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.